|
DK201370137A
|
|
Insecticide combination preparation for use against mammalian blood mites, especially cats and dogs
|
|
DK201170008A
|
|
Composition for long-term protection against fleas in mammals, especially cats and dogs
|
|
AU2008201425A1
|
|
Vaccination against the feline immunodeficiency virus
|
|
AU2007234633A1
|
|
Recombined porcine adenovirus based viral vaccines and vectors
|
|
AU2006202480A1
|
|
Porcine circo viruses, vaccines and diagnostic reagents I
|
|
AU2006200963A1
|
|
Compositions and vaccines containing antigen(s) of cryptosporidium parvum and of another pathogen
|
|
AU2005202233A1
|
|
DNA vaccines for pets and sport animals
|
|
AU2005201861A1
|
|
Insecticidal combination effective against fleas on mammals, particularly cats and dogs
|
|
US7211379B2
|
|
Prevention of myocarditis, abortion and intrauterine infection associated with porcine circovirus-2
|
|
US2005255127A1
|
|
Recombinant vaccine against West Nile Virus
|
|
AU2003257646A1
|
|
Direct pour-on skin solution for anitparasitic use in cattle and sheep
|
|
AU2003248395A1
|
|
Porcine CircoViruses, vaccines and diagnostic reagents
|
|
US7192594B2
|
|
Postweaning multisystemic wasting syndrome and porcine circovirus from pigs
|
|
EP1594537A1
|
|
Vaccination or immunization using a prime-boost regimen against brsv, bhv-1, bvdv, bpi-3
|
|
AU2002302120B2
|
|
Porcine circoviruses, vaccines and diagnostic reagents
|
|
EP1314727A1
|
|
Direct synthesis of quaternary phenanthridinium salts
|
|
WO03022886A1
|
|
Igf-1 as feline vaccine adjuvant, in particular against feline retroviruses
|
|
US7294338B2
|
|
Polynucleotide vaccine formula against canine pathologies, in particular respiratory and digestive pathologies
|
|
EP1914239A1
|
|
Attentuated gram negative bacteria
|
|
ZA200108340B
|
|
(S)-Enantiomer enriched fipronil composition.
|
